Published in Wiley Interdiscip Rev Dev Biol on August 21, 2013
A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. Elife (2014) 1.12
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ (2013) 1.06
Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors. Cancer Cell (2013) 1.00
Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut (2014) 1.00
Re-thinking cell cycle regulators: the cross-talk with metabolism. Front Oncol (2013) 0.92
Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal (2015) 0.92
EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection. Front Genet (2013) 0.91
Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 0.90
Epigenetic control of skin and hair regeneration after wounding. Exp Dermatol (2014) 0.89
INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform. Proc Natl Acad Sci U S A (2014) 0.87
Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase. Nat Commun (2013) 0.87
Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development. J Invest Dermatol (2016) 0.86
ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation. Mol Cancer Res (2013) 0.86
Targeting Mdmx to treat breast cancers with wild-type p53. Cell Death Dis (2015) 0.81
E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution. Cell Death Differ (2015) 0.81
Clinicopathological and Targeted Exome Gene Features of a Patient with Metastatic Acinic Cell Carcinoma of the Parotid Gland Harboring an ARID2 Nonsense Mutation and CDKN2A/B Deletion. Case Rep Oncol Med (2015) 0.80
Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. PLoS Pathog (2015) 0.80
CRY2 and FBXL3 Cooperatively Degrade c-MYC. Mol Cell (2016) 0.79
Arf induction by Tgfβ is influenced by Sp1 and C/ebpβ in opposing directions. PLoS One (2013) 0.79
Nuclear receptor NR5A2 controls neural stem cell fate decisions during development. Nat Commun (2016) 0.75
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
An oncogene-induced DNA damage model for cancer development. Science (2008) 11.60
Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer (2006) 11.48
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature (2006) 9.20
p16INK4a induces an age-dependent decline in islet regenerative potential. Nature (2006) 9.09
Cellular senescence in cancer and aging. Cell (2007) 9.04
The regulation of INK4/ARF in cancer and aging. Cell (2006) 8.75
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature (2006) 8.06
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (2000) 7.28
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature (2011) 6.25
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell (1999) 5.93
Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev (2005) 5.78
Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene (1997) 5.64
Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer (2008) 5.19
Divorcing ARF and p53: an unsettled case. Nat Rev Cancer (2006) 5.17
Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature (2010) 5.02
The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol (2001) 4.83
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell (2008) 4.71
Mouse development and cell proliferation in the absence of D-cyclins. Cell (2004) 4.69
Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature (2010) 4.36
Cancer stem cells: lessons from leukemia. Trends Cell Biol (2005) 3.90
Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature (2009) 3.90
Delayed ageing through damage protection by the Arf/p53 pathway. Nature (2007) 3.87
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature (2010) 3.77
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature (2001) 3.57
Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia. Genes Dev (2007) 3.31
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature (2007) 3.26
Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol (1999) 3.06
Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol (2009) 3.00
p53--a Jack of all trades but master of none. Nat Rev Cancer (2009) 2.96
The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer (2006) 2.85
Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature (2008) 2.82
Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med (2000) 2.81
INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One (2009) 2.77
Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood (2011) 2.16
Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. Genes Dev (2008) 1.79
The INK4 family of cell cycle inhibitors in cancer. Oncogene (1999) 1.70
Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol (2009) 1.64
Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr Biol (2004) 1.55
Small DNA tumor viruses: large contributors to biomedical sciences. Virology (2009) 1.48
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL. Genes Dev (2008) 1.33
Stem cells use distinct self-renewal programs at different ages. Cold Spring Harb Symp Quant Biol (2009) 1.13
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc Natl Acad Sci U S A (2007) 1.07